PURPLE INNOVATION, INC. PRPL
2.47
(0.07)
(2.76%)
as of 25 Sep
- Market cap
- $11.1M
- P/E
- 0.0×
Follow PRPL
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
0.22 | 0.16 | 0.16 | 0.09 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(104.44) | (12.88) | 23.98 | 60.08 | |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
0.41 | 0.38 | 0.40 | 0.58 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(8.83) | (5.26) | (23.44) | (83.58) | |
EV/FCF |
(6.60) | (4.23) | (11.43) | (24.69) | |
Quick Ratio |
0.59 | 0.65 | 0.49 | 0.23 | |
Current Ratio |
1.40 | 1.35 | 1.24 | 0.52 | |
Net Debt/EBITDA |
(30.04) | 39.17 | (7.59) | 491.50 | |
Debt/Assets |
34.06% | 37.57% | 43.83% | 48.02% | |
Debt/Equity |
(3.82) | (3.75) | (1.98) | (1.99) | |
Asset Turnover |
1.50 | 1.55 | 1.63 | 1.60 | |
Operating CF/Net income |
0.08 | 1.81 | (0.10) | (0.20) | |
Capex/Depreciation |
(0.09) | (0.50) | (0.46) | (0.52) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
1.99% | 1.85% | 2.56% | 2.53% | |
Selling, General and Administrative Expense of Revenue |
46.58% | 38.19% | 51.80% | 46.99% | |
Intangible Assets out of Total Assets |
0.02 | 0.02 | 0.02 | 0.02 | |
Share Based Compensation of Revenue |
0.35% | 0.33% | 0.16% | (0.38%) | |
Graham Net Nets |
(1.91) | (2.53) | (3.02) | (5.50) | |
Graham Number |
43.04 | 43.05 | 67.27 | 60.88 | |
Earnings Yield |
(56.75%) | (69.44%) | (87.72%) | (125.87%) | |
Free Cash Flow Yield |
(28.17%) | (56.37%) | (22.24%) | (27.27%) | |
Revenue per Share |
27.43 | 32.54 | 22.08 | 22.58 | |
Operating CF per Share |
(0.22) | (1.34) | 0.69 | 0.15 | |
Capex per Share |
(0.21) | (0.51) | (0.47) | (0.53) | |
Free Cash Flow per Share |
(0.44) | (1.85) | 0.22 | (0.38) | |
Cash per Share |
7.47 | 5.63 | 5.76 | 5.35 | |
Shareholders Equity per Share |
(6.21) | (6.86) | (13.87) | (14.66) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(6.21) | (6.86) | (13.87) | (14.66) | |
Free Cash Flow |
(1.89) | (8.01) | 0.96 | (1.65) | |
Working Capital |
39.31 | 35.20 | 22.36 | (105.24) | |
Capital Expenditures |
(0.92) | (2.21) | (2.03) | (2.30) | |
Net Current Asset Value |
(192.62) | (189.21) | (216.55) | (213.82) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.01 | 0.02 | 0.02 | 0.02 | |
Net Profit Margin |
(9.87%) | (2.28%) | (31.90%) | (3.29%) | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
27.44 | 37.16 | 22.77 | 23.66 | |
Average Payables |
33.03 | 40.48 | 37.17 | 33.57 | |
Average Inventory |
62.83 | 58.29 | 59.13 | 58.15 | |
Average Assets |
305.70 | 302.05 | 282.88 | 284.14 | |
Average Common Equity |
0.55 | (4.73) | (29.40) | (39.69) |
Columns are period end dates